Skip to content

Active ingredient

Rivaroxaban

43 finished FDA listings contain Rivaroxaban as their only active ingredient.

FDA NDC Directory

Ingredient names as written by FDA
RIVAROXABAN
Dosage forms
For Suspension, Granule, For Suspension, Tablet, Tablet, Coated, Tablet, Film Coated
Routes
Oral
Manufacturers / labelers
23
Strengths listed
10 mg/1 · 15 mg/1 · 155 mg/1 · 2.5 mg/1 · 20 mg/1
Brand names in FDA listings
Xarelto

RxNorm (National Library of Medicine)

Ingredient concept RxCUI 1114195

Drugs@FDA applications

Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.

ApplicationSponsorOriginal approvalListings
NDA 022406JANSSEN PHARMS2011-07-0111
NDA 215859JANSSEN PHARMS2021-12-201
ANDA 208557TARO2025-03-031
ANDA 208555LUPIN2025-03-031
ANDA 208544AUROBINDO PHARMA LTD2025-04-101
ANDA 217810APOTEX2025-05-021
ANDA 216995AIPING PHARM INC2025-05-143
ANDA 213114MACLEODS PHARMS2025-05-142
ANDA 208534DR REDDYS2025-05-141
ANDA 210301ALEMBIC2025-05-148
ANDA 219332ASCENT PHARMS INC2025-05-142
ANDA 218502ALKEM LABS LTD2025-06-261
ANDA 218117SCIEGEN PHARMS2025-07-312
ANDA 218445REGCON HOLDINGS2025-08-115
ANDA 218195LUPIN2025-09-251
ANDA 208546MSN2025-10-241
ANDA 208334MICRO LABS2026-06-301

Official labeling on DailyMed

Showing the 12 most recent of 27 labels.

Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.